Table 3.
Comparison of clinical parameters between low-risk polyps group and high-risk polyps group in prediabetes [±s, n (%)]
| Variable | Low-risk polyps group (n = 90) | High-risk polyps group (n = 158) | P-value |
|---|---|---|---|
| Sex (male) (%) | 43 (47.8) | 98 (62.5) | 0.029 |
| Age (year) | 54.7 ± 10.9 | 58.1 ± 12.4 | 0.012 |
| BMI (kg/m2) | 23.6 ± 3.3 | 24.9 ± 3.6 | 0.046 |
| WHR | 0.88 ± 0.08 | 0.92 ± 0.09 | 0.032 |
| SBP (mm Hg) | 122 ± 16 | 123 ± 15 | 0.876 |
| DBP (mm Hg) | 76 ± 14 | 77 ± 12 | 0.913 |
| FPG (mmol/L) | 5.8 ± 0.4 | 5.9 ± 0.6 | 0.882 |
| 2hPG (mmol/L) | 8.8 ± 0.9 | 10.3 ± 0.6 | < 0.001 |
| TG (mmol/L) | 1.61 ± 0.89 | 1.68 ± 0.91 | 0.621 |
| TCH (mmol/L) | 5.02 ± 0.88 | 5.17 ± 0.72 | 0.705 |
| FINS (mIU/L) | 12.62 ± 5.93 | 18.98 ± 8.23 | 0.047 |
| HOMA-IR | 3.38 ± 1.76 | 5.02 ± 2.28 | 0.034 |
| Adiponectin (mg/L) | 7.4 ± 3.5 | 3.7 ± 2.9 | < 0.001 |
| Visfatin (mg/L) | 12.1 ± 5.6 | 14.9 ± 7.7 | 0.351 |
| Leptin (ng/ml) | 24.6 ± 10.3 | 31.3 ± 13.5 | 0.289 |
| Resistin (ng/ml) | 7.9 ± 1.8 | 9.7 ± 2.2 | 0.402 |
| Current smoking (%) | 18 (20.0) | 77 (48.7) | 0.023 |
| Regular alcohol drinking (%) | 32 (35.6) | 65 (41.1) | 0.386 |
| Regular exercise (%) | 26 (28.9) | 27 (17.1) | 0.433 |
| Regular vegetables consumption (%) | 27 (30.0) | 42 (26.6) | 0.564 |
| Family history of colon cancer (%) | 5 (5.6) | 18 (11.4) | 0.035 |
Data are presented mean ± standard deviations or numbers (%); Differences between the two groups compared using the independent sample t-test to analyze the normally distributed continous variables, using the Mann-Whitney U test to analyze the abnormally distributed continous variables. And using x2 test to analyze the count data